• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Is the mobile health app market a “medium for mischief”? | MassDevice.com On Call

Is the mobile health app market a “medium for mischief”? | MassDevice.com On Call

November 14, 2012 By MassDevice staff

MassDevice On Call

MASSDEVICE ON CALL — The mobile app market could be a "medium for mischief" for some software writers who are making false claims and relying on shabby research to sell software, according to Federal Trade Commission attorney James Prunty.

The FTC has pursued lawsuits against some health-app-makers, including 2 who claimed they could turn a smartphones into an acne treatment product.

The FTC and the FDA has been in conversations about how best to oversee health-related apps and whether to pursue lawsuits against more companies making false claims about the potential health benefits of their mobile software products, which claim to relief pain, stress and other conditions, the Washington Post reported.

“Virtually any app that claims it will cure someone of a disease, condition or mental health condition is bogus,” health technology expert John Grohol told the newspaper. “Developers are just preying on people’s vulnerabilities.”

 Mass. Life Sciences Center launches 3rd grant program
The Massachusetts Life Sciences Center launched its 3rd grant-matching program for live-saving research in the lifesciences sector, offering up to $250,000 annually for up to 2 years to eligible applicants.  
Read more

 Better health through transcendental meditation
A 20-minute-per-session transcendental meditation regimen proved to significantly reduce death and adverse events in a group of African American patients with coronary heart disease.
Read more

 FBI investigates death of knee surgery patient
The FBI is "assessing" the death of a woman who died after having knee surgery at The Holy Family Hospital in Methuen, Mass., where family members claim hospital staff inappropriately left the patient alone in an un-monitored room where she died.
Read more

Filed Under: Health Information Technology, News Well Tagged With: On Call

More recent news

  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Philips prices $1.1B offering to pay off debt, finance green projects
  • Pixee Medical reports first knee arthroplasty cases using its augmented reality nav tech
  • Alpheus Medical raises $52M for ultrasound-activated tumor therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy